Instruction for use: Colfarit

Active substance Acetylsalicylic acid

ATX code N02BA01 Acetylsalicylic acid

Pharmacological group

Non-steroidal anti-inflammatory drug (NSAID) [Antiaggregants]

Non-steroidal anti-inflammatory drug (NSAID) [NSAIDs - Salicylic acid derivatives]

Nosological classification (ICD-10)

I21 Acute myocardial infarction

Myocardial infarction in the acute phase, Acute Myocardial Infarction, Myocardial infarction with pathologic Q wave and without, Myocardial infarction complicated by cardiogenic shock, Infarction left ventricular, Transmural myocardial infarction, Myocardial infarction netransmuralny (subendocardial), Netransmuralny myocardial infarction, Subendocardial myocardial infarction, The acute phase of myocardial infarction, Acute myocardial infarction, Sub-acute phase of myocardial infarction, Subacute phase of myocardial infarction, Thrombosis of the coronary arteries (the arteries), Threatened myocardial infarction, Myocardial infarction without Q wave

I74 Embolism and arterial thrombosis

Thrombosis of effort (tension), Arterial thrombosis, Arteriothrombosis, Subacute and chronic arterial thrombosis, Subacute thrombosis of peripheral arteries, Postoperative thrombosis, Vascular thrombosis, Vascular embolism, Thrombosis of aortocoronary shunt, Arterial thrombosis, Thrombosis of arteries, Coronary artery thrombosis, Coronary thrombosis, Thrombosis of blood vessels, Thrombosis with ischemic stroke, Thrombosis with general surgical operations, Thrombosis in Oncology Operations, Vascular thrombosis, Thrombus formation in the postoperative period, Thrombotic complications. Thromboembolic diseases, Thromboembolic complications, Thromboembolic syndrome, Thromboembolic complication, Thromboembolic complication in the postoperative period, Thromboembolism of arteries, Partial vascular thrombosis, Embolism, Embolism of arteries

I80 Phlebitis and thrombophlebitis

Diseases of peripheral vessels, Inflammation of superficial veins, Inflammatory diseases of veins, Deep venous thrombophlebitis, The disease of veins, Disease of the veins of the lower extremities, Diseases of peripheral vessels, Migrating phlebitis, Insufficiency of veins of lower extremities, Exacerbation of chronic thrombophlebitis, Acute thrombophlebitis,Acute thrombophlebitis of superficial veins, Periphlebitis, Periflebit surface, Superficial inflammation of veins, Surface thrombophlebitis, Surface phlebitis, Thrombophlebitis, Deep vein thrombophlebitis, Thrombophlebitis superficial, Phlebitis, Phlebitis of deep veins, Phlebitis of superficial veins, Phlebopathy, Chronic thrombophlebitis, Endophlebitis

I82 Embolism and thrombosis of other veins

Recurrent venous thrombosis, Postoperative thrombosis, Venous thrombosis, Acute venous thromboembolism, Recurrent vein thrombosis, Thrombosis of veins, Thrombosis of veins of internal organs, Venous thrombosis, Deep vein thrombosis, Thrombosis of blood vessels, Vascular thrombosis, Thrombosis of veins, Deep vein thrombosis, Thromboembolic diseases, Thromboembolism of veins, Severe venous thrombosis, Embolism, Embolism of veins, Thromboembolic complications

R07.2 Pain in the heart

neuroses of the heart, Myocardial ischemic pain, Pain syndrome in myocardial infarction, cardialgia, cardioneurosis, Cardiac syndrome, Pain in cardiac patients, Cardialgia on background dyshormonal myocardial dystrophy, Functional cardialgia, Psevdostenokardiya, pericardial pain

Composition and form of release

1 tablet contains 500 mg of microencapsulated acetylsalicylic acid; in the package of 50 pcs.

pharmachologic effect

Pharmacological action - anti-inflammatory, antipyretic, antiaggregational, analgesic.

Indications

Thrombophlebitis of superficial veins, prevention of thrombosis, embolism, myocardial infarction (secondary).

Contraindications

Hypersensitivity, peptic ulcer of the stomach and duodenum, aspirin asthma, hemorrhagic diathesis, hemophilia, hypoprotrombinemia, vitamin deficiency, kidney dysfunction, pregnancy, children's age (up to 1 year).

Side effects

Dyspeptic disorders, erosive and ulcerative lesions of the gastrointestinal tract, gastric bleeding, impaired liver and kidney function, thrombocytopenia, allergic reactions.

Interaction

Strengthens the effect of anticoagulants and oral hypoglycemic agents, NSAIDs, side effects of methotrexate, reduces the effectiveness of antidotal drugs.

Dosing and Administration

Inside, after eating, washed down with water, 1-2 tablets for 1-3 weeks. In the acute phase of thrombophlebitis - 1 tablet 3-4 times a day. For prevention - 1 tablet 1-3 times.

Storage conditions

In the dark place.

Keep out of the reach of children.

Shelf life

4,5 years.

Do not use after the expiry date printed on the package.